PATENT CLAIM ANALYSIS

Application Number: 16134736
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "266200"]

Abstract:
The present disclosure provides a method of treating a biliary duct cancer, such as cholangiocarcinoma, by administering a therapeutically effective amount of a compound of formula (I), in particular Varlitinib, an enantiomer thereof or a pharmaceutically acceptable salt of any one of the same.

Claim (Index 29):
A method according to  claim 26 , wherein each dose of cisplatin is 25 mg/m 2 .

Metadata:
- Claim Count in Document: 83.0
- Percentile: 97.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15757133', '15757189', '12763991', '12208227', '14477828']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7297151275087854
- 35 USC 102 Novelty (BERT): 0.5672438499673227
- Combined Prediction Score: 0.7134679997546391
- Mean Citation Score: 330.640524
- Max Citation Score: 470.00308
- Similarity Product: 348.88756024541857

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test